Responding to Higher-Than-Expected Infant Mortality Rates from Respiratory Syncytial Virus (RSV): Improving Treatment and Reporting Strategies

Overview

Journal Infect Drug Resist

Publisher Dove Medical Press

Date 2023 Feb 3

PMID 36733921

Authors

Julia Dvorkin

Julian De Luca

Damian Alvarez-Paggi

Mauricio T Caballero

Affiliations

Soon will be listed here.

Abstract

Respiratory syncytial virus (RSV) has a major role in respiratory infections in young infants around the world. However, substantial progress has been made in recent years in the field of RSV. A wide variety of observational studies and clinical trials published in the past decade provide a thorough idea of the health and economic burden of RSV disease in the developing world. In this review, we discuss the impact of RSV burden of disease, major gaps in disease estimations, and challenges in generating new therapeutic options and an immune response against the virus, and briefly describe next generation technologies that are being evaluated.

Citing Articles

Assessing the long-term economic impact of wheezing episodes after severe RSV disease in children from Argentina: a cost of illness analysis.

Dvorkin J, Pecenka C, Sosa E, Sancilio A, Duenas K, Rodriguez A BMJ Public Health. 2025; 2(1):e000975.

PMID: 40018190 PMC: 11812910. DOI: 10.1136/bmjph-2024-000975.

Cost of illness due to respiratory syncytial virus acute lower respiratory tract infection among infants hospitalized in Argentina.

Dvorkin J, Sosa E, Vodicka E, Baral R, Sancilio A, Duenas K BMC Public Health. 2024; 24(1):427.

PMID: 38336643 PMC: 10858556. DOI: 10.1186/s12889-024-17878-3.

The Estimate of Parental Quality of Life Loss Due to Respiratory Syncytial Virus (RSV) Hospitalization.

Wrotek A, Wrotek O, Jackowska T Diseases. 2023; 11(4).

PMID: 37873770 PMC: 10594483. DOI: 10.3390/diseases11040126.

References

Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2095-128. PMC: 10790329. DOI: 10.1016/S0140-6736(12)61728-0. View

Blanco J, Boukhvalova M, Morrison T, Vogel S . A multifaceted approach to RSV vaccination. Hum Vaccin Immunother. 2018; 14(7):1734-1745. PMC: 6067850. DOI: 10.1080/21645515.2018.1472183. View

Acosta P, Caballero M, Polack F . Brief History and Characterization of Enhanced Respiratory Syncytial Virus Disease. Clin Vaccine Immunol. 2015; 23(3):189-95. PMC: 4783420. DOI: 10.1128/CVI.00609-15. View

Shang Z, Tan S, Ma D . Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies. Int J Biol Sci. 2021; 17(14):4073-4091. PMC: 8495404. DOI: 10.7150/ijbs.64762. View

DeVincenzo J, Tait D, Efthimiou J, Mori J, Kim Y, Thomas E . A Randomized, Placebo-Controlled, Respiratory Syncytial Virus Human Challenge Study of the Antiviral Efficacy, Safety, and Pharmacokinetics of RV521, an Inhibitor of the RSV-F Protein. Antimicrob Agents Chemother. 2019; 64(2). PMC: 6985722. DOI: 10.1128/AAC.01884-19. View

Kazi A, Aguolu O, Mughis W, Ahsan N, Jamal S, Khan A . Respiratory Syncytial Virus-Associated Mortality Among Young Infants in Karachi, Pakistan: A Prospective Postmortem Surveillance Study. Clin Infect Dis. 2021; 73(Suppl_3):S203-S209. PMC: 8411247. DOI: 10.1093/cid/ciab488. View

Liu L, Johnson H, Cousens S, Perin J, Scott S, Lawn J . Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet. 2012; 379(9832):2151-61. DOI: 10.1016/S0140-6736(12)60560-1. View

Atwell J, Geoghegan S, Karron R, Polack F . Clinical Predictors of Critical Lower Respiratory Tract Illness Due to Respiratory Syncytial Virus in Infants and Children: Data to Inform Case Definitions for Efficacy Trials. J Infect Dis. 2016; 214(11):1712-1716. DOI: 10.1093/infdis/jiw447. View

Saha S, Pandey B, Choudekar A, Krishnan A, Gerber S, Rai S . Evaluation of case definitions for estimation of respiratory syncytial virus associated hospitalizations among children in a rural community of northern India. J Glob Health. 2015; 5(2):010419. PMC: 4652925. DOI: 10.7189/jogh.05.020419. View

10.

Polack F, Alvarez-Paggi D, Libster R, Caballero M, Blair R, Hijano D . Fatal enhanced respiratory syncytial virus disease in toddlers. Sci Transl Med. 2021; 13(616):eabj7843. PMC: 10712289. DOI: 10.1126/scitranslmed.abj7843. View

11.

Ofman G, Pradarelli B, Caballero M, Bianchi A, Grimaldi L, Sancilio A . Respiratory Failure and Death in Vulnerable Premature Children With Lower Respiratory Tract Illness. J Infect Dis. 2020; 222(7):1129-1137. PMC: 7459133. DOI: 10.1093/infdis/jiaa046. View

12.

Li Y, Johnson E, Shi T, Campbell H, Chaves S, Commaille-Chapus C . National burden estimates of hospitalisations for acute lower respiratory infections due to respiratory syncytial virus in young children in 2019 among 58 countries: a modelling study. Lancet Respir Med. 2020; 9(2):175-185. DOI: 10.1016/S2213-2600(20)30322-2. View

13.

Sadoff J, De Paepe E, DeVincenzo J, Gymnopoulou E, Menten J, Murray B . Prevention of Respiratory Syncytial Virus Infection in Healthy Adults by a Single Immunization of Ad26.RSV.preF in a Human Challenge Study. J Infect Dis. 2021; 226(3):396-406. PMC: 9417128. DOI: 10.1093/infdis/jiab003. View

14.

Stevens M, Rusch S, DeVincenzo J, Kim Y, Harrison L, Meals E . Antiviral Activity of Oral JNJ-53718678 in Healthy Adult Volunteers Challenged With Respiratory Syncytial Virus: A Placebo-Controlled Study. J Infect Dis. 2018; 218(5):748-756. DOI: 10.1093/infdis/jiy227. View

15.

Munoz F, Cramer J, Dekker C, Dudley M, Graham B, Gurwith M . Vaccine-associated enhanced disease: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data. Vaccine. 2021; 39(22):3053-3066. PMC: 7901381. DOI: 10.1016/j.vaccine.2021.01.055. View

16.

Polack F, Teng M, Collins P, Prince G, Exner M, Regele H . A role for immune complexes in enhanced respiratory syncytial virus disease. J Exp Med. 2002; 196(6):859-65. PMC: 2194058. DOI: 10.1084/jem.20020781. View

17.

Nyawanda B, Mott J, Njuguna H, Mayieka L, Khagayi S, Onkoba R . Evaluation of case definitions to detect respiratory syncytial virus infection in hospitalized children below 5 years in Rural Western Kenya, 2009-2013. BMC Infect Dis. 2016; 16:218. PMC: 4875667. DOI: 10.1186/s12879-016-1532-0. View

18.

Gonzalez P, Prado C, Leiva E, Carreno L, Bueno S, Riedel C . Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells. Proc Natl Acad Sci U S A. 2008; 105(39):14999-5004. PMC: 2567482. DOI: 10.1073/pnas.0802555105. View

19.

Bukreyev A, Yang L, Fricke J, Cheng L, Ward J, Murphy B . The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes. J Virol. 2008; 82(24):12191-204. PMC: 2593351. DOI: 10.1128/JVI.01604-08. View

20.

Li Y, Wang X, Blau D, Caballero M, Feikin D, Gill C . Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022; 399(10340):2047-2064. PMC: 7613574. DOI: 10.1016/S0140-6736(22)00478-0. View